Tricuspid regurgitation therapy, two more left atrial appendage trials, and reflections on being too soft on medical science are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Tricuspid Regurgitation
Trilogy TAVR Safe, Effective in Aortic Regurgitation
https://www.medscape.com/viewarticle/997782
The TRILUMINATE Transcatheter Tricuspid Repair Trial: Positive but No Benefit?
https://www.medscape.com/viewarticle/989105
Transcatheter Tricuspid Valve Repair Effective, Safe for Regurgitation: TRILUMINATE
https://www.medscape.com/s/viewarticle/989103
- TRILUMINATE NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2300525
II. LAA Occlusion
Different Strengths for LAA Closure Devices?
https://www.medscape.com/viewarticle/962893
- Swiss Apero – Original paper https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057859
- Swiss Apero – One-year https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.067599
Peri-device Leaks After Watchman https://pubmed.ncbi.nlm.nih.gov/35902169/
TAVR With Left Atrial Appendage Occlusion Non-inferior to TAVR Plus Medical Therapy https://www.medscape.com/viewarticle/997725
- WATCH TAVR Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.067312
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net